In a remarkable move, the Department of Justice (DOJ) recently sought dismissal of 11 False Claims Act (FCA) cases, each of which assert that patient assistance services supplied by pharmaceutical manufacturers constitute...more
On Monday, June 19, 2017, Elizabeth Gurrieri became the second former employee of Insys Therapeutics (Insys) to plead guilty to federal anti-kickback charges related to the drug Subsys, an expensive fentanyl-based painkiller....more
6/28/2017
/ Anti-Kickback Statute ,
Bribery ,
Criminal Prosecution ,
Guilty Pleas ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Indictments ,
Insurance Fraud ,
Kickbacks ,
Off-Label Use ,
Pharmaceutical Industry ,
PHI ,
Physicians ,
Prior Authorization